Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

VNRX
VolitionRX Limited Common Stock
stock NYSEAMERICAN

At Close
May 9, 2025 3:59:30 PM EDT
0.4980USD-3.768%(-0.0195)154,419
0.5000Bid   0.5100Ask   0.0200Spread
Pre-market
May 7, 2025 9:02:30 AM EDT
0.5302USD+2.454%(+0.0127)0
After-hours
May 9, 2025 4:09:30 PM EDT
0.4750USD-4.618%(-0.0230)2,000
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 20, 2022
08:30AM EST  Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the   PR Newswire
Dec 20, 2021
08:35AM EST  Life Sciences Companies Investor Presentations Now Available for On-Demand   PR Newswire
Dec 16, 2021
08:06AM EST  Volition Enters Supply And Licensing Contract Fo Nu.Q Vet Cancer Screening Test In Asia   Benzinga
08:02AM EST  Volition Executes its First Supply and Licensing Contract for its Nu.Q(r) Vet   PR Newswire
Dec 9, 2021
12:20PM EST  Life Sciences Virtual Investor Conference: Company Executives Present Live   PR Newswire
Nov 22, 2021
10:12AM EST  VNRX: 3Q revenues from Nu.Q Vet Test remain steady as company is in advanced term sheet discussions with 3 major global veterinary companies   Benzinga
Nov 16, 2021
09:04AM EST  Aegis Capital Maintains Buy on VolitionRX, Lowers Price Target to $9   Benzinga
Nov 15, 2021
09:00AM EST  -- 30 Minute presenting time slots from 9am to 1pm ESTNovember 16, 2021 -- Presentation times and links distributed for all presenting companies -- Investors will be provided time after presentation to ask questions -- Welcome all institutional and retail investors   GlobeNewswire Inc
Nov 10, 2021
06:24PM EST  VolitionRX Q3 EPS $(0.13) Misses $(0.11) Estimate, Sales $25.48K Miss $140.00K Estimate   Benzinga
04:10PM EST  VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business   PR Newswire
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 8, 2021
08:31AM EST  VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and   PR Newswire
Nov 4, 2021
09:17AM EDT  Volition Veterinary Presents 2 Posters At 2021 Veterinary Cancer Society Conference   Benzinga
08:34AM EDT  Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society   PR Newswire
Sep 24, 2021
10:44AM EDT  VolitionRX Earnings Perspective: Return On Capital Employed   Benzinga
Sep 20, 2021
08:35AM EDT  Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.   GlobeNewswire Inc
Sep 10, 2021
08:35AM EDT  Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.   GlobeNewswire Inc
Aug 18, 2021
03:41PM EDT  VNRX: Revenues from Nu.Q Vet Cancer Screening Test steady from beta test; Silver One expected to generate revenues in late 2021.   Benzinga
Aug 12, 2021
09:04AM EDT  -- 30 Minute presenting time slots from 9am to 12pm ESTAugust 17th, 2021 -- Presentation times and links distributed for all presenting companies -- Investors will be provided time after presentation to ask questions to management teams -- We welcome all institutional and retail investors   GlobeNewswire Inc
Aug 11, 2021
04:32PM EDT  VolitionRX Reports Q2 2021 Cash And Cash Equivalents As Of June 30, 2021 ~$27.9M   Benzinga
04:10PM EDT  VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business   PR Newswire
09:06AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
04:27AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 4, 2021
08:15AM EDT  VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and   PR Newswire
Jul 22, 2021
08:05AM EDT  Volition Highlights Abstracts Released This Week At The International Society on Thrombosis and Haemostasis (ISTH) Congress 2021 Showing Nu.Q NETs Assay Results In COVID-19 Risk Stratification And Disease Monitoring   Benzinga
08:02AM EDT  Volition's Nu.Q(r) NETs Assay Demonstrates Promising Results in COVID-19 Risk   PR Newswire
Jun 28, 2021
08:35AM EDT  Life Sciences Investor Forum today announced that the presentations from the June 24th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.   GlobeNewswire Inc
Jun 21, 2021
08:35AM EDT  VolitionRx Limited to Webcast Live at Life Sciences Investor Forum   GlobeNewswire Inc
08:35AM EDT  Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.   GlobeNewswire Inc
Jun 18, 2021
10:21AM EDT  Looking Into VolitionRX's Return On Capital Employed   Benzinga
May 25, 2021
12:31PM EDT  VNRX: Revenues from Nu.Q Vet cancer screening test are ramping up; Silver One expected to generate revenues in 2021   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
04:10PM EDT  VolitionRx Limited Announces First Quarter 2021 Financial Results and Business   PR Newswire
12:47PM EDT  Earnings Scheduled For May 11, 2021   Benzinga
May 6, 2021
08:15AM EDT  VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and   PR Newswire
Mar 31, 2021
08:32AM EDT  VolitionRx Limited Highlights Publication Of Nu.Q Capture Mass Spectrometry Paper   Benzinga
08:30AM EDT  VolitionRx Limited Announces Publication of Significant Nu.Q(r) Capture Mass   PR Newswire
Mar 30, 2021
08:35AM EDT  VolitionRx Appoints Tom Butera DVM As CEO For Volition Veterinary Subsidiary   RTTNews
08:30AM EDT  VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for   PR Newswire
Mar 29, 2021
04:10PM EDT  VolitionRx Limited Appoints Two New Directors   PR Newswire
08:35AM EDT  Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.   GlobeNewswire Inc
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 25, 2021
01:43PM EDT  From BZ Biotech Conference: VolitionRx's Powell Notes Blood Diagnostics Have Several Advantages Over Other Diagnostics Like Colonoscopy, Fecal Exam, Mammography, Etc.   Benzinga
01:40PM EDT  From BZ Biotech Conference: VolitionRx's Powell Discussing Nu.Q Vet Cancer Screening Test, Is Working Exclusively In Blood Diagnostics   Benzinga
01:39PM EDT  From BZ Biotech Conference: VolitionRx's Powell Highlighting Co.'s 3 Pillars: Nu-Q, Nu-Q Capture, Nu-Q Vet   Benzinga
01:37PM EDT  From BZ Biotech Conference: VolitionRx Head Of Investor Relations, Scott Powell, Begins Presentation   Benzinga
Mar 22, 2021
04:14PM EDT  VolitionRX Reports Cash And Cash Equivalents As Of December 31, 2020 Totaled ~$19.4M Compared With $17M YoY   Benzinga
04:10PM EDT  VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and   PR Newswire
08:35AM EDT  VolitionRx Limited to Webcast Live at Life Sciences Investor Forum   GlobeNewswire Inc
03:33AM EDT  Earnings Scheduled For March 22, 2021   Benzinga
Mar 19, 2021
08:35AM EDT  Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.   GlobeNewswire Inc
Mar 17, 2021
08:13AM EDT  VolitironRx Highlights Poster Presentation 'Therapeutic Removal of NETs from Blood in a Pig Model of Sepsis'   Benzinga
08:02AM EDT  New Data Demonstrates Nu.Q(r) is Effective in Monitoring Treatment of Sepsis   PR Newswire
Mar 16, 2021
08:30AM EDT  VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and   PR Newswire
Mar 10, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2021   Benzinga
06:26AM EST  Cantor Fitzgerald Initiates Coverage On VolitionRX with Overweight Rating, Announces Price Target of $8   Benzinga
Mar 8, 2021
04:15PM EST  VolitionRx Limited to Present at Conferences in March 2021   PR Newswire
Feb 12, 2021
09:25AM EST  VolitionRx Limited Announces Closing of $20 Million Underwritten Public   PR Newswire
Feb 10, 2021
09:21AM EST  VolitionRx Prices $20 Mln Underwritten Public Offering Of Common Stock   RTTNews
09:21AM EST  VolitionRx Prices 3,809,524 Share Common Stock Offering For Gross Proceeds Of $20M; Implied Price ~$5.25/Share   Benzinga
09:19AM EST  VolitionRx Limited Announces Pricing of $20 Million Underwritten Public   PR Newswire
Feb 9, 2021
04:03PM EST  VolitionRx Limited Announces Proposed Underwritten Public Offering Of Common Stock   Benzinga
04:01PM EST  VolitionRx Limited Announces Proposed Underwritten Public Offering of Common   PR Newswire
Feb 8, 2021
08:35AM EST  Small and Microcap Company Investor Presentations Now Available for On-Demand   PR Newswire
Feb 2, 2021
07:51AM EST  VolitionRx Appoints New CFO Terig Hughes   RTTNews
07:46AM EST  VolitionRx Provides Business Update; Says Appoints New CCO, CTO   Benzinga
07:45AM EST  VolitionRx Provides a Business Update and Appoints Key Officers to Drive   PR Newswire
Feb 1, 2021
03:30PM EST  VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com February   PR Newswire
Jan 28, 2021
08:35AM EST  Live Investor Conference & Webinar: Small and Microcap Company Showcase on   PR Newswire
06:27AM EST  National Taiwan University Hospital Presents Data On Nu.Q Assay Performance At World Conference On Lung Cancer   RTTNews
06:22AM EST  National Taiwan University Hospital Presents Data on Nu.Q(tm) Assay Performance   PR Newswire
Jan 25, 2021
09:34AM EST  Aegis Capital Maintains Buy on VolitionRX, Raises Price Target to $10   Benzinga
08:51AM EST  VolitionRx Opens Its New Manufacturing Facility In Belgium   RTTNews
08:46AM EST  VolitionRx Reports Will Open 'Silver One' Manufacturing Facility In Isnes, Belgium   Benzinga
08:45AM EST  VolitionRx Limited Opens its New Manufacturing Facility in Belgium   PR Newswire
Jan 6, 2021
08:28AM EST  VolitionRx Granted An Additional $4 Mln In Non-Dilutive Funding   RTTNews
08:27AM EST  VolitionRx Announces $4M In Non-Dilutive Funding   Benzinga
08:25AM EST  VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding   PR Newswire
Dec 21, 2020
09:50AM EST  Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.   GlobeNewswire Inc
Dec 14, 2020
08:29AM EST  Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.   GlobeNewswire Inc
Dec 3, 2020
08:30AM EST  VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors   PR Newswire
Dec 1, 2020
08:45AM EST  Volition Launches Nu.Q(tm) Vet Cancer Screening Test in the U.S.   PR Newswire
08:45AM EST  Volition Launches Nu.Q Vet Cancer Screening Test In The US   Benzinga
Nov 19, 2020
07:02AM EST  VolitionRx Limited to Present COVID-19 Data At MEDICA 2020   Benzinga
Nov 12, 2020
04:10PM EST  VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business   PR Newswire
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 10, 2020
08:02AM EST  Volition Veterinary Presents Expert Report Ahead of First Product Launch   PR Newswire
Nov 9, 2020
08:02AM EST  VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and   PR Newswire
Oct 21, 2020
08:01AM EDT  VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020   PR Newswire
Oct 20, 2020
07:01AM EDT  VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020   PR Newswire
Oct 16, 2020
08:06AM EDT  Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding Its Nu.Q Vet Cancer Screening Test In Lymphoma, Hemangiosarcoma To Be Presented At 2020 VCS Virtual Annual Conference   Benzinga
08:00AM EDT  Regarding its Nu.Q(tm) Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference   PR Newswire
Oct 14, 2020
08:00AM EDT  VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020   PR Newswire
Oct 12, 2020
08:04AM EDT  Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference   Benzinga
08:00AM EDT  Regarding its Nu.Q(tm) Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference   PR Newswire
Sep 29, 2020
08:01AM EDT  VolitionRx Limited Announces Virtual Capital Markets Day 2020   PR Newswire
Sep 14, 2020
08:35AM EDT  Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com   GlobeNewswire Inc
Sep 8, 2020
12:08PM EDT  2 Conferences Are Going Virtual This Month One On Cannabis And Another Life Sciences   Benzinga
Sep 1, 2020
08:02AM EDT  VolitionRx Limited to Present at Conferences in September 2020   PR Newswire
Aug 19, 2020
11:55AM EDT  Aegis Capital Maintains Buy on VolitionRX, Lowers Price Target to $8   Benzinga
Aug 13, 2020
04:12PM EDT  VolitionRx Q2 Cash, Cash Equivalents ~$21.3M   Benzinga
04:10PM EDT  VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business   PR Newswire
04:03AM EDT  Earnings Scheduled For August 13, 2020   Benzinga
Aug 10, 2020
07:42AM EDT  VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and   PR Newswire
Jul 15, 2020
04:49AM EDT  55 Biggest Movers From Yesterday   Benzinga
Jul 14, 2020
07:01AM EDT  Shares of VolitionRx Ltd. (VNRX) are soaring over 80% in pre-market today, after the company announced that results from two proof of concept clinical studies using its Nu.Q assays have been submitted for peer review and would be available on BIORXIV.ORG shortly.   RTTNews
06:24AM EDT  VolitionRx Limited (VNRX) said results from two proof of concept clinical studies using its Nu.Q assays have been submitted for peer review, demonstrating promising results for the company's COVID-19 triage test. Volition announced in April that the company was actively developing a COVID-19 triage test.   RTTNews
06:17AM EDT  Volition Announces Clinical Trials Results For Its Novel COVID-19 Triage Test Have Been Submitted For Peer Review   Benzinga
06:04AM EDT  Volition Announces Results From Two Proof Of Concept Clinical Studies Using Its Nu.Q Assays   RTTNews
06:02AM EDT  Volition Announces Clinical Trials Results For Its Novel COVID-19 Triage Test Had Been Submitted For PEer Review   Benzinga
06:00AM EDT  Volition Announces Promising Clinical Trials Results for its Novel COVID-19   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC